CN113995801B - Medical application of polygonum multiflorum and aloe cathartic capsules - Google Patents
Medical application of polygonum multiflorum and aloe cathartic capsules Download PDFInfo
- Publication number
- CN113995801B CN113995801B CN202110828042.4A CN202110828042A CN113995801B CN 113995801 B CN113995801 B CN 113995801B CN 202110828042 A CN202110828042 A CN 202110828042A CN 113995801 B CN113995801 B CN 113995801B
- Authority
- CN
- China
- Prior art keywords
- parts
- capsule
- polygonum multiflorum
- drunk
- aloe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 45
- 241001289529 Fallopia multiflora Species 0.000 title claims abstract description 14
- 241001116389 Aloe Species 0.000 title claims description 20
- 235000011399 aloe vera Nutrition 0.000 title claims description 20
- 239000003814 drug Substances 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 230000002075 anti-alcohol Effects 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 6
- 241000132012 Atractylodes Species 0.000 claims description 6
- 244000183685 Citrus aurantium Species 0.000 claims description 6
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 6
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 241000205407 Polygonum Species 0.000 claims description 4
- 230000004149 ethanol metabolism Effects 0.000 claims description 4
- 230000035987 intoxication Effects 0.000 claims description 3
- 231100000566 intoxication Toxicity 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 2
- 240000002624 Mespilus germanica Species 0.000 claims 2
- 231100000419 toxicity Toxicity 0.000 claims 1
- 230000001988 toxicity Effects 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 25
- 239000000203 mixture Substances 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 10
- 230000009194 climbing Effects 0.000 abstract description 7
- 230000002040 relaxant effect Effects 0.000 abstract description 6
- 238000010171 animal model Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 206010010774 Constipation Diseases 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000007848 Alcoholism Diseases 0.000 description 5
- 201000007930 alcohol dependence Diseases 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 206010019133 Hangover Diseases 0.000 description 4
- 244000182216 Mimusops elengi Species 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 3
- 241000223201 Metarhizium Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000046198 Triteleia hyacinthina Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 208000013527 cardiovascular neoplasm Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for dispelling effects of alcohol, belongs to the field of medicines, and particularly relates to application of polygonum multiflorum to preparation of anti-alcohol medicines. The research shows that the Hui Tongbian capsule can shorten the sobering-up time, prolong the drunk latency and the climbing time, and the Hui Tongbian capsule can delay the drunk mice, help the drunk mice to recover the normal state and has remarkable anti-alcohol effect. The polygonum multiflorum capsule for relaxing bowels has good effect of improving drunk states of experimental animals, has remarkable effect of protecting livers and brains, and has wide application prospect.
Description
Technical Field
The invention relates to a traditional Chinese medicine composition for dispelling effects of alcohol, and belongs to the field of medicines. In particular to the application of the polygonum multiflorum cathartic capsule in preparing anti-alcohol drugs.
Background
China is a auspicious place of wine culture, is the earliest country invented and researched in the world, and contains a large amount of wine culture in the culture development process of thousands of years in China. Wine is widely used in daily etiquette and social society, but a large amount of drinking is extremely harmful to the body and even causes death. The international health organization indicates that: alcoholism is one of the current world's first nuisances, and in developed countries alcoholism and cardiovascular disease, neoplasms and is known as a three major public health problem.
The wine is a common beverage in daily life at present, and can be used for promoting the drinking in special occasions, but excessive drinking or long-term drinking is not good for the self health of people, and brings a plurality of problems to families and society.
Acute alcoholism refers to the state of excitation or inhibition of the central nervous system caused by short-term overdose of alcohol or alcoholic drinks, and is known as acute alcoholism or acute alcoholism, commonly known as intoxication. Also called paradox, harm, toxic wine, bloating, distention, syncope, etc. Clinically, there is strong wine flavor in the expired air and vomit. It is usually caused by improper eating and drinking, and wine is used as syrup.
In recent years, there have been many reports and products on medicinal health foods, beverages and medicines for alleviating hangover: for example, the patent application CN107715089A adopts the Chinese medicinal formula of Chinese magnoliavine fruit, dried orange peel, ginger, dark plum fruit, bitter apricot seed, poria cocos and mulberry leaf which are matched to relieve the effect of alcohol and protect liver; publication number CN107951934a tabletted candy formulated with artichoke extract, hoke extract, white hyacinth bean, kudzuvine root, sorbitol, ascorbic acid, mannitol and magnesium stearate; the patent application CN107648429A is prepared from semen Phaseoli Radiati, pericarpium Citri Tangerinae, radix Puerariae, semen Hoveniae, radix Ophiopogonis, saviae Miltiorrhizae radix, polygoni Multiflori radix, semen Cassiae, herba Gynostemmatis, fructus Hippophae, and folium Menthae. However, the anti-alcoholic products with different formulas have quite different effects, and some traditional Chinese medicine components have low content of effective substances, cannot play a good role in anti-alcoholic and liver-protecting, and even use traditional Chinese medicines with definite liver toxicity as the constituent components. Most products in the market have the defects of more indications, wide treatment range, undefined curative effect, weak pertinence and the like.
Chinese patent CN100453105C discloses a composition with the functions of relaxing the bowels, expelling toxin, reducing weight and lowering lipid and a preparation method, and the composition is approved by production, and the product is the first aloe cathartic capsule. The product is a compound Chinese medicinal preparation prepared from eight Chinese medicinal formulas of polygonum multiflorum, aloe, semen cassiae, medlar, donkey-hide gelatin, ginseng, bighead atractylodes rhizome and immature bitter orange by extraction and processing, and can be used for treating functional constipation in a targeted manner. The first-pass constipation relieving capsule prescription is a clinical proved recipe of the old traditional Chinese medicine, which combines clinical experience according to the theory of traditional Chinese medicine, and is supplemented with blood-replenishing and dryness-moistening products and qi-tonifying and spleen-invigorating products in the products for relaxing bowel, purging turbid and expelling toxin, the medicine has the functions of reinforcing and reducing the turbid and relieving the distension and fullness, and has the functions of reinforcing and reducing the general purpose, reducing the middle warmer, reinforcing and reducing the middle warmer, keeping the general purpose, relaxing the general purpose, restraining the general purpose, reinforcing and reducing the stagnation, and protecting the healthy energy. So as to guide the whole formula to act on the spleen and stomach and enable the middle-jiao spleen and stomach to recover the normal functions of ascending the clear and descending the turbid. The first-aloe constipation relieving capsule has definite curative effect, quick response and good treatment effect on constipation caused by toxin and internal accumulation and yin fluid deficiency.
Chinese patent CN106124685A discloses a quality detection method of a Chinese patent medicine, namely, a first-aloe cathartic capsule, for treating constipation. Chinese patent CN111228389A discloses the use of a traditional Chinese medicine composition, in particular to the use of a polygonum multiflorum cathartic capsule in preparing medicines for preventing and treating abdominal distension.
At present, no research or report on the anti-alcohol aspect of the polygonum multiflorum and aloe cathartic capsules exists.
Disclosure of Invention
The technical problem to be solved by the invention is to develop a new application aiming at the product 'first-unit laxative capsule' on the basis of Chinese patent CN 100453105C. The product is applied to preparation of anti-alcoholic drugs.
The formulation patent of the polygonum multiflorum cathartic capsule product is CN100453105C, and the invention is named as a composition with the functions of relaxing the bowels, expelling toxin, losing weight and reducing fat and a preparation method thereof.
The aim of the invention is mainly realized by the following technical scheme:
the traditional Chinese medicine composition is prepared from polygonum multiflorum, aloe, semen cassiae, medlar, donkey-hide gelatin, ginseng, bighead atractylodes rhizome and immature bitter orange serving as raw materials.
The invention relates to application of a traditional Chinese medicine composition in preparation of anti-hangover medicines.
The application of the traditional Chinese medicine composition in preparing medicines for reducing the drunk rate and shortening the drunk time.
The anti-hangover refers to preventing drunk or improving symptoms after overdrinking.
Wherein the components are as follows in parts by weight: 60-150 parts of polygonum multiflorum, 100-200 parts of aloe, 80-180 parts of semen cassiae, 30-150 parts of medlar, 30-150 parts of donkey-hide gelatin, 20-100 parts of ginseng, 20-100 parts of bighead atractylodes rhizome, 50-200 parts of immature bitter orange, and the preferable method is as follows: 120 parts of polygonum multiflorum, 160 parts of aloe, 140 parts of cassia seed, 75 parts of medlar, 75 parts of donkey-hide gelatin, 50 parts of ginseng, 50 parts of bighead atractylodes rhizome, and 120 parts of immature bitter orange.
The components in the composition are prepared according to a preparation method or an extraction method of the components in a composition with the functions of relaxing bowels, expelling toxin, losing weight and reducing blood fat in a preparation method of the patent CN 100453105C.
The compositions of the present invention may be prepared to include, but are not limited to, pharmaceuticals, nutraceuticals, and foods.
The traditional Chinese medicine composition provided by the invention can also contain pharmaceutically acceptable auxiliary materials, and the traditional Chinese medicine composition is prepared into a pharmaceutical preparation according to a conventional preparation process, such as: pill, tablet, granule, capsule, oral liquid, unguent, emulsion, chewing agent, injection, etc.
Preferably tablets, capsules and granules, wherein the medicine is a first aloe cathartic capsule,
The invention provides application of the traditional Chinese medicine composition in preparation of anti-alcohol medicines.
The dosage of the traditional Chinese medicine composition for alleviating hangover is 1mg/kg.d-100mg/kg.d, preferably 20mg/kg.d.
The traditional Chinese medicine composition has the following advantages when being used for dispelling the effects of alcohol:
(1) The research shows that the Hui Tongbian capsule can shorten the sobering-up time, prolong the drunk latency and the climbing time, and the Hui Tongbian capsule can delay the drunk mice, help the drunk mice to recover the normal state, and has a certain anti-alcohol effect. The polygonum multiflorum-aloe cathartic capsule has good effect of improving the drunk state of experimental animals, has the effect of obviously protecting the liver and the brain, and has the prospect of obviously developing the anti-alcohol effect.
(2) The components of the traditional Chinese medicine composition provided by the invention are natural components extracted from traditional Chinese medicines, and the traditional Chinese medicine composition has the characteristics of safety and no toxicity.
Pharmacodynamic test example
The test product capsule (the first aloe cathartic capsule) is produced by Lunan Sanpu pharmaceutical Co., ltd, and is named Z20150041.
Example 1 behavioral effects of the Metarhizium Hui Constipation Capsule on drunk mice
ICR mice, lunan pharmaceutical Co., ltd., laboratory animal license number SYXK (Lun) 2018000.
60 Male ICR mice were randomly divided into 5 groups according to body weight: the blank control group, the drunk model control group, the low dose group of the first aloe cathartic capsule, the dose group of the first aloe cathartic capsule and the high dose group of the first aloe cathartic capsule, and each group comprises 12 parts.
No water was allowed for one night before the test. Mice in the blank group were perfused with 10 mL/(kg.bw) of distilled water;
Model mice and the low, medium and high dose mice of the first meta-cathartic capsule were perfused with 10 mL/(kg.bw) of 50% (V/V) ethanol.
After 30min, the mice of the blank group and the mice of the model group were perfused with 12 mL/(kg.bw) of distilled water;
the low, medium and high dose group mice of the Hui Tongbian capsule are respectively infused with the low, medium and high dose Hui Tongbian capsules according to the corresponding doses (50, 100, 200 mg/(kg.bw).
The mice are subjected to a behavioural experiment, which is divided into an anti-regular reflection experiment and a climbing experiment, the changes of the appearance states and behaviors of the mice in each group are observed, and the sobering time, the drunk latency and the climbing time are recorded. The results are shown in Table 1.
Table 1 results of the behavioral experiments in mice of each experimental group
P < 0.05, p < 0.01 compared to model group.
The results in table 1 show that the low dose group of the first aloe cathartic capsule has significantly reduced sobering-up time (P < 0.05) and significantly prolonged drunk latency and climbing time (P < 0.05) compared to the drunk model control group; the sobering-up time of the dosage group and the high dosage group in the first-meta cathartic capsule is obviously reduced (P is less than 0.01), and the drunk latency and climbing time are obviously prolonged (P is less than 0.01).
According to the results of Table 1, the Hui Tou Jiaonang has the advantages of shortening the sobering time, prolonging the drunk latency and the climbing time, indicating that the Hui Jiaonang can delay the drunk mice, help the drunk mice to recover the normal state, and have a certain anti-alcohol effect.
EXAMPLE 2 Effect of the Hui Tou Gangsu capsule on the memory Capacity of mice with Long-term alcohol injury
48 ICR mice are randomly divided into 4 groups, and each group comprises 12 mice, namely a blank control group, a model control group, and a first aloe cathartic capsule low-dose group and a first aloe cathartic capsule high-dose group.
Each group except the blank control group is filled with gastric alcohol (45%) 0.01ml/g every day, and the low-dose and high-dose groups of the first-aloe cathartic capsules are respectively filled with gastric alcohol for 30min before the gastric alcohol filling, and the doses are respectively 50mg/kg and 200mg/kg; the model control group was filled with an equal amount of purified water and the blank control group was filled with an equal amount of purified water for two consecutive weeks.
And then carrying out a water maze experiment, wherein pool water is dyed black by ink, so that the pool water is in clear contrast with a white mouse, and the acquisition of data is facilitated. Experiments were performed for a total of 5d and the results were recorded for 3 d. Training for 4 times per day, wherein the selected pool entering positions are opposite sides of the platform and adjacent quadrants, the mouse is driven to enter water towards the pool wall at the position of 1/2 radian of the edge of the quadrant, and meanwhile, the camera starts to record the platform searching time, searching distance and searching track type of the mouse searching platform. The results are shown in Table 2.
TABLE 2 influence on memory Capacity of mice with Long-term alcohol injury
&p<0.05,&& P < 0.01 compared to the blank.
P < 0.05, p < 0.01 compared to model control.
Proved by researches, the polygonum multiflorum-aloe cathartic capsule has good effect of improving the drunk state of experimental animals, has the effect of obviously protecting the liver and the brain, and has the prospect of obviously developing the anti-alcohol effect.
EXAMPLE 3 Effect of the Metarhizium Hui Constipation Capsule on liver alcohol dehydrogenase content
The number of Kunming mice was 48, the male weight was 20+ -2 g, and the mice were randomly divided into 4 groups of 12 mice each according to the body weight. No water was allowed for 12 hours before the experiment.
Except for the blank control group, the mice in the model group and the first meta-constipation capsule high and low dose groups are filled with 56-degree white spirit, 0.05ml/10g, and are continuously fed for 14 days, the mice in the model group are fed with standard feed, drink water freely, and the blank control group is fed with normal saline.
From day 1, 1 hour after drinking, the low and high dosage groups of the first aloe cathartic capsules are respectively administered into the first aloe cathartic capsules according to the dosage of 0.1ml/10g of stomach irrigation, and the dosages are respectively 50mg/kg and 200mg/kg. The model control group was filled with an equal amount of purified water, and the blank control group was filled with an equal amount of purified water.
And continuously administering for 14d, taking the liver after the experiment is finished, adding lysate for homogenating, and measuring the content of the alcohol dehydrogenase in the liver by adopting a colorimetric method.
TABLE 3 influence of the Metarhizium Diels Constipation Capsule on the content of alcohol dehydrogenase in the liver of mice
P < 0.05, p < 0.01 compared to model group.
The results showed that compared with the model group, the liver of the mice in the group of the polygoni multiflori constipation relieving capsules had elevated ADH activity and significant differences.
ADH activity in liver plays an important role in ethanol metabolism, and the activity is increased, so that the ethanol metabolism can be accelerated. The first-aloe cathartic capsule increases ADH activity in liver and accelerates ethanol metabolism.
The above examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present invention should be made in the equivalent manner, and the embodiments are included in the protection scope of the present invention.
Claims (4)
1. The application of the polygonum multiflorum-aloe cathartic capsule in preparing anti-alcohol drugs is characterized in that the polygonum multiflorum-aloe cathartic capsule is prepared from polygonum multiflorum, aloe, semen cassiae, medlar, donkey-hide gelatin, ginseng, bighead atractylodes rhizome and immature bitter orange in parts by weight: 120 parts of polygonum multiflorum, 160 parts of aloe, 140 parts of semen cassiae, 75 parts of medlar, 75 parts of donkey-hide gelatin, 50 parts of ginseng, 50 parts of bighead atractylodes rhizome and 120 parts of immature bitter orange.
2. The use according to claim 1, wherein the anti-alcohol means preventing drunk or ameliorating symptoms after overdrinking.
3. The use of claim 1, wherein the medicament promotes ethanol metabolism, prevents or reduces ethanol toxicity.
4. The use according to claim 1, wherein the medicament reduces the rate of intoxication and shortens the duration of intoxication.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010738741 | 2020-07-28 | ||
CN2020107387415 | 2020-07-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113995801A CN113995801A (en) | 2022-02-01 |
CN113995801B true CN113995801B (en) | 2024-06-07 |
Family
ID=79921264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110828042.4A Active CN113995801B (en) | 2020-07-28 | 2021-07-22 | Medical application of polygonum multiflorum and aloe cathartic capsules |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113995801B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748765A (en) * | 2004-09-17 | 2006-03-22 | 鲁南制药集团股份有限公司 | Composition with catharsis and toxin expelling, fat reducing and weight reducing function and preparing method |
CN107596241A (en) * | 2017-09-29 | 2018-01-19 | 黑龙江中医药大学 | A kind of anti-alcohol and liver-protection traditional Chinese medicine composition and its production and use |
CN111298005A (en) * | 2018-11-23 | 2020-06-19 | 鲁南制药集团股份有限公司 | Use of 'Jiehui Tongbiang' capsule and its preparing process |
-
2021
- 2021-07-22 CN CN202110828042.4A patent/CN113995801B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748765A (en) * | 2004-09-17 | 2006-03-22 | 鲁南制药集团股份有限公司 | Composition with catharsis and toxin expelling, fat reducing and weight reducing function and preparing method |
CN107596241A (en) * | 2017-09-29 | 2018-01-19 | 黑龙江中医药大学 | A kind of anti-alcohol and liver-protection traditional Chinese medicine composition and its production and use |
CN111298005A (en) * | 2018-11-23 | 2020-06-19 | 鲁南制药集团股份有限公司 | Use of 'Jiehui Tongbiang' capsule and its preparing process |
Also Published As
Publication number | Publication date |
---|---|
CN113995801A (en) | 2022-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102885912A (en) | Shangxia beverage for relaxing bowels and preparation method thereof | |
CN101513463A (en) | Chinese medicine composition for relieving alcoholism and protecting liver and preparation method thereof | |
CN106135891A (en) | A kind of health food to alcoholic liver injury with defencive function | |
CN101284064A (en) | Preparation method of kudzuvine root and indigowoad root tablets for reducing fat and alleviating hangover | |
CN105362384A (en) | Traditional Chinese medicine composition for dispelling the effects of alcohol and sobering up | |
CN110693946A (en) | Formula with bowel relaxing function and preparation method thereof | |
CN101002857B (en) | Traditional Chinese medicine composition, and its use | |
CN1425447A (en) | Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method | |
CN103142815B (en) | Purgative composition, preparation method and application thereof | |
CN113995801B (en) | Medical application of polygonum multiflorum and aloe cathartic capsules | |
US20230125425A1 (en) | Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof | |
CN101380452A (en) | Preparation method of no-alcohol type Shexiang Qushu liquid oral preparation | |
CN1443533A (en) | Application of proanthcyanidin compound in preparation of alcoholism-relieving liver-protecting product | |
CN1218743C (en) | Chinese medicine for treating hyperthyroidism | |
CN112546135A (en) | Traditional Chinese medicine composition for dispelling effects of alcohol, sobering up and protecting liver and application thereof | |
CN110522784A (en) | A kind of drug and preparation method thereof can be used for intestines problem | |
CN111249381A (en) | Application of composition in preparation of medicine for preventing and treating constipation | |
CN113855734B (en) | Medicine for treating diarrhea and preparation method thereof | |
CN109125623A (en) | It is a kind of for treating the pharmaceutical composition of hepatopathy | |
CN115737777B (en) | Compound anti-alcohol traditional Chinese medicine composition and preparation method thereof | |
CN105031033B (en) | Blood sugar reducing pharmaceutical composition containing boxthorn leaves and preparation method and application thereof | |
KR102217732B1 (en) | Composition for preventing and improving the development of premature pseudo-breast | |
CN115887573B (en) | Traditional Chinese medicine composition for slowing down aging and improving brain function degradation and preparation method | |
KR101307726B1 (en) | A composition comprising the extract of Angelica dahurica for preventing and treating drug intoxication or withdrawal symptoms | |
CN106474417A (en) | A kind of Chinese medicine composition of Dealcoholic sobering-up and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |